<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical, Inc.

    Collegium Pharmaceutical is a specialty pharmaceutical company committed to being ...

    Collegium Pharmaceutical is a specialty pharmac...

    Filing Type:    PU
    Quadrant Biosciences Inc

    Quadrant Biosciences Inc

    Quadrant Biosciences is an epigenetic diagnostics company with a focus on the earl...

    Quadrant Biosciences is an epigenetic diagnosti...

    Filing Type:    RA
    Applied Genetic Technologies Corporation

    Applied Genetic Technologies Corporation

    AGTC is a clinical-stage biotechnology company that uses a proprietary gene therap...

    AGTC is a clinical-stage biotechnology company ...

    Filing Type:    PU
    Eidos Therapeutics, Inc.

    Eidos Therapeutics, Inc.

    Eidos is a clinical stage biopharmaceutical company focused on addressing the larg...

    Eidos is a clinical stage biopharmaceutical com...

    Filing Type:    PU
    PRA Health Sciences, Inc.

    PRA Health Sciences, Inc.

    At PRA Health Sciences, we work side-by-side with our clients, to move drug discov...

    At PRA Health Sciences, we work side-by-side wi...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Precipio, Inc.

    Precipio, Inc.

    Precipio has built a platform designed to eradicate the problem of misdiagnosis by...

    Precipio has built a platform designed to eradi...

    Filing Type:    PU
    Alpine Immune Sciences, Inc.

    Alpine Immune Sciences, Inc.

    Alpine is a development-stage specialty pharmaceutical company focused on discover...

    Alpine is a development-stage specialty pharmac...

    Filing Type:    PU
    Merrimack Pharmaceuticals, Inc.

    Merrimack Pharmaceuticals, Inc.

    Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...

    Merrimack is a biopharmaceutical company based ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.